Takeda Pharmaceutical Company Limited (TKD.F) Stock Price, News & Chart

	TKD.F	INDSWFTLAB.NS	MOREPENLAB.NS	STAR.NS	TEVA	4547.T
Market cap	61.21B	31.52B	53.21B	92.87B	48.81B	161.53B
P/E (TTM)	319.3	37.0	28.3	15.1	97.3	14.4
Forward P/E	21.8	—	—	11.7	13.4	17.6
Price/book	1.5	2.1	3.9	2.7	6.1	0.7
Dividend yield	3.10%	—	0.20%	0.49%	—	3.46%
1-year change	+58.12%	+240.08%	+113.46%	+5.71%	+71.10%	−6.36%
Today	+3.57%	−3.72%	−4.17%	−0.65%	−0.14%	+3.06%

Market cap

61.21B

31.52B

53.21B

92.87B

48.81B

161.53B

P/E (TTM)

319.3

37.0

28.3

15.1

97.3

14.4

Forward P/E

21.8

—

11.7

13.4

17.6

Price/book

1.5

2.1

3.9

2.7

6.1

0.7

Dividend yield

3.10%

—

0.20%

0.49%

—

3.46%

1-year change

+58.12%

+240.08%

+113.46%

+5.71%

+71.10%

−6.36%

Today

+3.57%

−3.72%

−4.17%

−0.65%

−0.14%

+3.06%

Company	Mkt cap	Price	Today
Ind-Swift Laboratories LimitedINDSWFTLAB.NS · Drug Manufacturers - Specialty & Generic	31.52B	356.75	−3.72%
Morepen Laboratories LimitedMOREPENLAB.NS · Drug Manufacturers - Specialty & Generic	53.21B	97.10	−4.17%
Strides Pharma Science LimitedSTAR.NS · Drug Manufacturers - Specialty & Generic	92.87B	1,007.60	−0.65%
Teva Pharmaceutical Industries LimitedTEVA · Drug Manufacturers - Specialty & Generic	48.81B	41.85	−0.14%
Kissei Pharmaceutical Co., Ltd.4547.T · Drug Manufacturers - Specialty & Generic	161.53B	3,870.00	+3.06%
Solara Active Pharma Sciences LimitedSOLARA.NS · Drug Manufacturers - Specialty & Generic	31.04B	643.30	−0.25%
Windlas Biotech LimitedWINDLAS.NS · Drug Manufacturers - Specialty & Generic	19.01B	921.25	+5.47%
The United Laboratories International Holdings Limited3933.HK · Drug Manufacturers - Specialty & Generic	15.37B	7.800	+6.41%

Company	Mkt cap	Price	Today
Yuyu Pharma, Inc.000220.KS · Jecheon-si, South Korea	58.66B	3,725.00	+0.40%
Sun Pharma Advanced Research Company LimitedSPARC.NS · Mumbai, India	63.66B	196.16	+5.84%
Suven Life Sciences LimitedSUVEN.BO · Hyderabad, India	63.96B	275.75	−0.14%
FDC LimitedFDC.BO · Mumbai, India	63.76B	391.65	+0.13%
Morepen Laboratories LimitedMOREPENLAB.NS · Gurugram, India	53.21B	97.10	−4.17%
H. Lundbeck A/S0ND5.IL · Valby, Denmark	55.52B	55.40	+0.73%
KYORIN Pharmaceutical Co., Ltd.4569.T · Tokyo, Japan	66.01B	1,149.00	+4.64%
Ildong Holdings Co., Ltd.000230.KS · Seoul, South Korea	65.20B	5,650.00	+0.89%

Company	Mkt cap	Price	Today
Cardinal Health, Inc.CAH · Medical Distribution	60.65B	261.93	+3.55%
Align Technology, Inc.A1LG34.SA · Medical Instruments & Supplies	64.08B	225.50	+9.57%
CSL LimitedCSJ.F · Biotechnology	59.76B	124.54	+1.83%
Merck KGaA1MRK.MI · Drug Manufacturers - Specialty & Generic	59.17B	136.10	+1.42%
Yuyu Pharma, Inc.000220.KS · Drug Manufacturers - Specialty & Generic	58.66B	3,725.00	+0.40%
Cencora, Inc.ABG.F · Medical Distribution	59.48B	311.70	+2.63%
Sun Pharma Advanced Research Company LimitedSPARC.NS · Drug Manufacturers - Specialty & Generic	63.66B	196.16	+5.84%
argenx SEARGX · Biotechnology	58.57B	931.38	+3.36%

Company	Mkt cap	Price	Today
Chugai Pharmaceutical Co., Ltd.CUP.F · Chuo, Japan	65.86B	40.02	+4.33%
Daiichi Sankyo Company, LimitedD4S.F · Chuo, Japan	31.06B	17.05	+5.64%
Sumitomo Electric Industries, Ltd.5802.T · Chuo, Japan	4.47T	1,431.00	−7.23%
Bridgestone Corporation5108.T · Chuo, Japan	5.25T	4,256.00	+6.13%
Astellas Pharma Inc.4503.T · Chuo, Japan	4.79T	2,672.50	+6.88%
Mitsui Fudosan Co., Ltd.8801.T · Chuo, Japan	4.68T	1,737.50	+6.27%
SMC Corporation6273.T · Chuo, Japan	3.69T	59,130.00	−4.17%
Konami Group CorporationKNM.L · Chuo, Japan	3.89T	28,660.00	+19.37%

Company	Mkt cap	Price	Today
Ipca Laboratories LimitedIPCALAB.NS · life sciences	494.62B	1,949.60	−1.14%
Yuyu Pharma, Inc.000220.KS · life sciences	58.66B	3,725.00	+0.40%
Dr. Reddy's Laboratories LimitedRDDA.F · life sciences	10.75B	12.90	+2.38%
Glenmark Pharmaceuticals LimitedGLENMARK.BO · life sciences	701.47B	2,485.50	−0.65%
Aurobindo Pharma LimitedAUROPHARMA.BO · life sciences	1.04T	1,788.30	+5.13%
Gufic Biosciences LimitedGUFICBIO.NS · life sciences	43.57B	434.45	+1.29%
Korea United Pharm Inc.033270.KS · life sciences	254.57B	16,050.00	+1.20%
Daewoong Pharmaceutical Co., Ltd069620.KS · life sciences	1.23T	106,700.00	+3.69%

Company	Mkt cap	Price	Today
KYORIN Pharmaceutical Co., Ltd.4569.T · Correlation 0.39	66.01B	1,149.00	+4.64%
Gilead Sciences, Inc.GIS.F · Correlation 0.32	191.58B	154.46	+0.89%
Takeda Pharmaceutical Company LimitedTKPHF · Correlation 0.31	66.85B	41.85	+2.30%
Astellas Pharma Inc.YPH.F · Correlation 0.30	26.36B	14.70	+5.76%

Company	Mkt cap	Price	Today
Astellas Pharma Inc.YPH.F	26.36B	14.70	+5.76%
Takeda Pharmaceutical Co., Ltd.TKPHF	66.85B	41.85	+2.30%
EISAI CO. LTD.EII.F	8.28B	29.32	+5.92%
Takeda Pharmaceutical Co. Ltd.RTKDA.F	61.66B	19.30	+5.46%
GILEAD SCIENCES INC.GIS.F	191.58B	154.46	+0.89%

Seeking Alpha·6d agoNegative

Takeda Pharmaceutical's Earnings Growth Has Yet To Translate To Higher Cash Flow

Takeda Pharmaceutical is reiterated as a hold, with concerns about its ability to replace major drug revenues and current valuation. Read more on TAK stock here. - Takeda Pharmaceutical is reiterated as a Hold, with concerns about its…

TAK BMY NVDA SPCX

The Globe and Mail·6d agoNegative

Bernstein Keeps Their Hold Rating on Takeda Pharmaceutical Co (TKPHF)

In a report released on January 16, Miki Sogi from Bernstein maintained a Hold rating on Takeda Pharmaceutical Co, with a price target of Yen4,700.00. The company’s shares closed last Tuesday at Yen5,073.00. Sogi covers the Healthcare…

USFD AZN JPM DB

MarketScreener·6d agoPositive

Takeda Pharmaceutical Raises Annual Guidance

Published on 10/29/2026 at 03:28 am EDT - Modified on 10/29/2026 at 03:29 am EDT Takeda Pharmaceutical raised its annual earnings forecasts, after swinging to a net profit in the second quarter. The Japanese drugmaker on Thursday reported…

LLY NVO TAK JNJ

Markets Daily·5d agoPositive

Takeda Pharmaceutical (NYSE:TAK) Posts Earnings Results, Beats Expectations By $0.37 EPS

Posted by Danessa Lincoln on Oct 30th, 2026 Takeda Pharmaceutical (NYSE:TAK – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.14 by…

TAK LLY BMY

MarketScreener·6d agoPositive

Takeda Pharmaceutical Eyes 2027 Japan Filing for Gastric Cancer Treatment

Takeda Pharmaceutical is targeting 2027 to file for regulatory approval in Japan for its experimental gastric cancer drug, arcotatug tavatecan, following positive results from a phase 3 clinical... Takeda Pharmaceutical Company Limited…

AZN

Seeking Alpha·6d ago

Takeda Pharmaceutical Company Limited 2026 Q2 - Results - Earnings Call Presentation

2026-10-30. The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction with their 2026 Q2 earnings call. The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction…

NVDA ABOS TAK PHAT

Seeking Alpha·Oct 29Positive

Takeda Pharmaceutical Non-GAAP EPS of ¥308.00, revenue of ¥2407B; upgrades FY 2026 outlook

Takeda Pharmaceutical reports 1H revenue up 8.4% year over year and non-GAAP EPS of ¥308. - Takeda Pharmaceutical press release (TAK): 1H Non-GAAP EPS of ¥308.00. - Adjusted Free Cash Flow was JPY 325.7 billion. - FY2026 full-year outlook…

GME TAK

Markets Daily·Oct 27Positive

Takeda Pharmaceutical (TAK) Expected to Announce Earnings on Thursday

Posted by Danessa Lincoln on Oct 27th, 2026 Check Out Our Latest Research Report on TAK Takeda’s portfolio includes treatments such as Entyvio for inflammatory bowel disease, Takhzyro for hereditary angioedema, and medicines for certain…

TAK LLY ALKS

24/7 Wall St.·Oct 15Positive

Takeda Pharmaceutical TAK Clears Its 52-Week High at $19.45

As seen on the 24/7 Wall St. homepage on October 15, 2026. Takeda Pharmaceutical touched $19.45, a fresh 52-week high that clears the September 17 peak by 2.1%. The ADR and the OTC line are both at the top of their range. Takeda…

TAK LLY JNJ PFE

MarketScreener·Oct 15Positive

Takeda Pharmaceutical Company Limited Presents Phase 2/3 IgGNITE Study Results Of Investigational Subcutaneous TAK-881 In Primary Immunodeficiency Disease At ESID 2026

Published on 10/14/2026 at 09:37 am EDT 11.9 g/L) were above accepted protective thresholds against infections. Delivering equivalent bodyweight-adjusted IG dosing in a concentrated 20% solution reduced total infusion volume by 50%. This…

GILD

Days on the list

30 d

1 yr

Best

Trending

—

Install

Takeda Pharmaceutical Company Limited

Key statistics

Against its peers

Latest news